This CPB has been revised to clarify a selection criterion for wearable cardioverter-defibrillators – “Either documented prior myocardial infarction or dilated cardiomyopathy and a measured LVEF less than or equal to 35 %” has been changed to “Either documented prior myocardial infarction or dilated cardiomyopathy and a measured LVEF less than or equal to 35 %, in whom duration of decreased LVEF is less than 90 days, and recheck of LVEF is planned at 90 days.  After the initial 90 day approval, an extension on a month-to-month basis may be obtained to bridge the time until automated implantable cardioverter defibrillator (AICD) implant or heart transplant, but the wearable device had no indication for extended usage if a destination therapy is not planned”.